Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5920648 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17786 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7990074 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL525378 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL524846 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7309478 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL123324 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4424351 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6242099 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6238780 | 1.00 | GPR84 (1.00) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144729-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4731174-A1 | COSMETIC COMPOSITION BASED ON CHITOSAN AND AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND | L'OREAL (FR) | 2026-04-29 | — | — | EP | claimed |
| EP-4731169-A1 | COMPOSITION WITH CHITOSAN AND A NATURAL RESIN | L'OREAL (FR) | 2026-04-29 | — | — | EP | claimed |
| EP-4731310-A1 | COMPOSITION WITH CHITOSAN AND A MODIFIED POLYSACCHARIDE | L'OREAL (FR) | 2026-04-29 | — | — | EP | claimed |
| US-12606701-B2 | Polymer composition and molded article | TORAY INDUSTRIES, INC. (JP) | 2026-04-21 | — | — | US | claimed |
| WO-2025263641-A1 | COMPOSITION COMPRISING GLYCOLIPID, CATIONIC POLYMER AND (POLY)HYDROXY ACID | L'OREAL (FR) | 2025-12-26 | — | — | WO | claimed |
| EP-4637684-A1 | COMPOSITION WITH CHITOSAN | L'OREAL (FR) | 2025-10-29 | — | — | EP | claimed |
| EP-4637685-A1 | COMPOSITION WITH CHITOSAN | L'OREAL (FR) | 2025-10-29 | — | — | EP | claimed |
| EP-4611719-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2025-09-10 | — | — | EP | claimed |
| EP-4608352-A1 | AQUEOUS MAKE-UP-REMOVING COMPOSITION HAVING A MILD PEELING EFFECT | L'OREAL (FR) | 2025-09-03 | — | — | EP | claimed |
| EP-0586575-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1994-03-16 | — | — | EP | claimed |
| WO-1992020738-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1992-11-26 | — | — | WO | claimed |
| WO-1992018116-A1 | COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING | YU RUEY J (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0508324-A2 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Yu, Ruey J., Dr. (US) | 1992-10-14 | — | — | EP | claimed |
| US-5106894-A | Fluoroethylene vinyl ether resin containing coating composition | DIEFENDORF ROBERT E (US) | 1992-04-21 | — | — | US | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| EP-0000560-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-HYDROXYCARBOXYLIC ACIDS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-02-03 | — | — | EP | claimed |
| US-4204044-A | SELECTIVE ASYMMETRIC, ENZYMATIC DEHYDROGENATIKN USING STREPTOMYCES, PSEUDOMONAS, BACILLUS OR CORYNEFORM MICROORGANISMS | HOFFMANN-LA ROCHE INC. (US) | 1980-05-20 | — | — | US | claimed |
| EP-0000560-A1 | Process for the preparation of optically active alpha-hydroxycarboxylic acids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606701-B2 | Polymer composition and molded article | MGAM, MGAM2, ACP1 | GPR84 4244/4885FFAR1 647/4885MAPT 231/4885 |
| US-20260144729-A1 | A CLEANSING COMPOSITION | SMURF1, CUTA, S100B | GPR84 675/4885FFAR1 720/4885MAPT 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.